Reset
Showing 15 of 95 academic articles

ACtriplet: An improved deep learning model for activity cliffs prediction by integrating triplet loss and pre-training

Xinxin Yu, Yimeng Wang, Long Chen, Weihua Li et al. • Journal of Pharmaceutical Analysis (2025)

Activity cliffs (ACs) are generally defined as pairs of similar compounds that only differ by a minor structural modification but exhibit a large difference in their binding affinity for a given target. ACs offer crucial insights that aid m...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.jpha.2025.101317

DeepTox: Toxicity Prediction using Deep Learning

Andreas Mayr, Günter Klambauer, Thomas Unterthiner, Sepp Hochreiter • Frontiers in Environmental Science (2016)

The Tox21 Data Challenge has been the largest effort of the scientific community to compare computational methods for toxicity prediction. This challenge comprised 12,000 environmental chemicals and drugs which were measured for 12 differen...

OPENALEX cc-by DOI: https://doi.org/10.3389/fenvs.2015.00080

The rise of deep learning in drug discovery

Hongming Chen, Ola Engkvist, Yinhai Wang, Marcus Olivecrona et al. • Drug Discovery Today (2018)

Over the past decade, deep learning has achieved remarkable success in various artificial intelligence research areas. Evolved from the previous research on artificial neural networks, this technology has shown superior performance to other...

OPENALEX cc-by DOI: https://doi.org/10.1016/j.drudis.2018.01.039

Deep Learning in Drug Discovery

Erik Gawehn, Jan A. Hiss, Gisbert Schneider • Molecular Informatics (2015)

Artificial neural networks had their first heyday in molecular informatics and drug discovery approximately two decades ago. Currently, we are witnessing renewed interest in adapting advanced neural network architectures for pharmaceutical ...

OPENALEX DOI: https://doi.org/10.1002/minf.201501008

Deep Learning in Chemistry

Adam C. Mater, Michelle L. Coote • Journal of Chemical Information and Modeling (2019)

Machine learning enables computers to address problems by learning from data. Deep learning is a type of machine learning that uses a hierarchical recombination of features to extract pertinent information and then learn the patterns repres...

OPENALEX DOI: https://doi.org/10.1021/acs.jcim.9b00266

Knowledge-transfer learning for prediction of matrix metalloprotease substrate-cleavage sites

Yanan Wang, Jiangning Song, Tatiana T. Marquez-Lago, André Leier et al. • Scientific Reports (2017)

Abstract Matrix Metalloproteases (MMPs) are an important family of proteases that play crucial roles in key cellular and disease processes. Therefore, MMPs constitute important targets for drug design, development and delivery. Advanced pro...

DOAJ Open Access (DOAJ) DOI: 10.1038/s41598-017-06219-7

Machine Learning in Materials Science

Tim Mueller, Aaron Gilad Kusne, Rampi Ramprasad • Reviews in computational chemistry (2016)

This chapter addresses the role that data-driven approaches, especially machine learning methods, are expected to play in materials research in the immediate future. Machine learning, an important part of artificial intelligence, has made m...

OPENALEX DOI: https://doi.org/10.1002/9781119148739.ch4

Machine learning in chemoinformatics and drug discovery

Yu‐Chen Lo, Stefano Rensi, Wen Torng, Russ Biagio Altman • Drug Discovery Today (2018)

Chemoinformatics is an established discipline focusing on extracting, processing and extrapolating meaningful data from chemical structures. With the rapid explosion of chemical 'big' data from HTS and combinatorial synthesis, machine learn...

OPENALEX cc-by DOI: https://doi.org/10.1016/j.drudis.2018.05.010 PMC: 6078794

Advances in ligand-targeted nanodelivery systems for leukemia therapy: from single- to dual-ligand strategies

Mingxin Hu, Chaoxing He, Jintao Hao, Nannan Qi et al. • Journal of Translational Medicine (2026)

Abstract Background Leukemia is a highly heterogeneous and aggressive hematological malignancy. Current therapeutic approaches (e.g. chemotherapy, radiotherapy, small-molecule targeted therapies, and hematopoietic stem cell transplantation,...

DOAJ Open Access (DOAJ) DOI: 10.1186/s12967-026-07966-w

Artificial Intelligence in Drug Design

Gerhard Heßler, Karl H. Baringhaus • Molecules (2018)

Artificial Intelligence (AI) plays a pivotal role in drug discovery. In particular artificial neural networks such as deep neural networks or recurrent networks drive this area. Numerous applications in property or activity predictions like...

OPENALEX cc-by DOI: https://doi.org/10.3390/molecules23102520 PMC: 6222615

Design of the Digital Pathology Workspace for Artificial Intelligence Integration

Elena Guerini-Rocco, Chiara Frascarelli, Joana Sorino, Francesca Maria Porta et al. • Applied Sciences (2026)

Designing an optimal digital pathology workspace is essential to ensure diagnostic accuracy and safeguard the long-term well-being of pathologists. While digital pathology improves reproducibility, facilitates multidisciplinary collaboratio...

DOAJ Open Access (DOAJ) DOI: 10.3390/app16126021

Artificial Intelligence for Clinical Trial Design

Stefan Harrer, Pratik P. Shah, Bhavna Josephine Antony, Jianying Hu • Trends in Pharmacological Sciences (2019)

Clinical trials consume the latter half of the 10 to 15 year, 1.5-2.0 billion USD, development cycle for bringing a single new drug to market. Hence, a failed trial sinks not only the investment into the trial itself but also the preclinica...

OPENALEX cc-by-nc-nd DOI: https://doi.org/10.1016/j.tips.2019.05.005